AnalystsElliot WilburElliot Wilbur's Stock Forecasts
AnalystsElliot Wilbur
Analyst Ranking
Bottom 5%
#4341 out of 4563 analysts
Average Return
-12.82%
Win Rate
30%16 out of 53
Risk vs Reward
Poor
Good
Elliot Wilbur's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Petiq IncPETQ | +144.62% | $7.80 | $19.08 | 2022-10-24 - 2023-10-24 | Buy |
Adma Biologics IncADMA | +102.22% | $1.35 | $2.73 | 2021-10-25 - 2022-10-25 | Buy |
Adma Biologics IncADMA | +98.11% | $1.59 | $3.15 | 2021-11-10 - 2022-11-10 | Strong Buy |
Dermira IncDERM2 | +73.63% | $34.51 | $9.10 | 2017-03-15 - 2018-03-16 | Sell |
Ani Pharmaceuticals IncANIP | +64.50% | $34.00 | $55.93 | 2022-08-08 - 2023-08-08 | Buy |
Elliot Wilbur Analyst Color
Get additional color on Elliot Wilbur's coverage of popular stocks
Elliot Wilbur's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sol Gel Technologies LtdSLGL | 7 | Strong Buy | $7.00 | +660.87% | Maintains | 8 months ago |
Adma Biologics IncADMA | 4 | Strong Buy | $6.00 | -7.12% | Maintains | 8 months ago |
Ani Pharmaceuticals IncANIP | 5 | Buy | $49.00 | -25.11% | Maintains | a year ago |
Organon & CoOGN | 1 | Buy | $33.00 | N/A | Initiates Coverage On | a year ago |
Perrigo Co PLCPRGO | 5 | Buy | $43.00 | N/A | Maintains | a year ago |
Petiq IncPETQ | 4 | Buy | $16.00 | N/A | Maintains | 2 years ago |
Polypid LtdPYPD | 3 | Buy | $120.00 | N/A | Downgrades | 2 years ago |
Covetrus IncCVET | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Plx Pharma IncPLXPQ | 3 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Antares Pharma IncATRS | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Viatris IncVTRS | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Teva Pharmaceutical Industries LtdTEVA | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Flexion Therapeutics IncFLXN | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zoetis IncZTS | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Elanco Animal Health IncELAN | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Dermira IncDERM2 | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Allergan PLCAGN | 2 | Buy | $198.00 | N/A | Maintains | 5 years ago |
Amphastar Pharmaceuticals IncAMPH | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Buy | $490.00 | N/A | Initiates Coverage On | 7 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Lannett Co IncLCINQ | 2 | Buy | $172.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.